Botulism

Current Treatment Options in Neurology

Volumn 5, Issue 1, 2003, Pages 23-31

  Davis, Larry E ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Botulinum Toxin; Cervical Dystonia; Compound Muscle Action Potential; Heroin; Main Drug Interaction

Indexed keywords

EID: 0345319811     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-003-0020-1     Document Type: Article

References (20)

1. van Emergen E: A new anaerobic bacillus and its relation to botulism. Rev Infect Dis 1979, 1:701–719.
2. Hatheway CL: Botulism: the present status of the disease. Curr Top Microbiol Immunol 1995, 195:55–75. Excellent microbiologic description of C. botulinum organisms and good review of the various clinical forms that botulism may develop.
3. Arnon SS, Schechter R, Inglesby TV, et al.: Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001, 285:1059–1070. Best review of inhalational botulism and newest Centers for Disease Control and Prevention recommendations for use of botulinum antitoxin.
4. Long SS: Clostridium botulinum (botulism). In Principles and Practice of Pediatric Infectious Diseases. Edited by Long SS, Pickering LK, Prober CG. New York: Churchill Livingston; 1997:1085–1093. This is an excellent review of clinical features and supportive treatment of infant botulism.
5. Simpson LL: Botulism toxin: potent poison, potent medicine. Hosp Pract 1999, 34:87–91. This is an excellent recent review of the mechanism of action of botulinum toxin.
6. Shipiro RL, Hatheway C, Swerdlow DL: Botulism in the United States: a clinical and epidemiological review. Ann Intern Med 1998, 129:221–228.
7. Weber JT, Goodpasture HC, Alexander H, et al.: Wound botulism in a patient with a tooth abscess: case report and review. Clin Infect Dis 1993, 16:635–639.
8. Werner SB, Passaro D, McGee J, et al.: Wound botulism in California, 1951–1998: recent epidemic in heroin injectors. Clin Infect Dis 2000, 31:1018–1024. Best description of increase in wound botulism in intravenous drug users from contaminated heroin.
9. Long SS: Infant botulism. Concise Rev Pediatr Infect Dis 2001, 20:707–709.
10. Midura TF: Update: infant botulism. Clin Microbiol Rev 1996, 9:119–125.
11. Arnon SS: Infant botulism. In Textbook of Pediatric Infectious Diseases, edn 4. Edited by Feigin RD, Cherry JD. Philadelphia: Saunders; 1998:1570–1577. Best review of human botulinum immune-globulin for infant botulism.
12. Davis LE: Botulinum toxin: from poison to medicine. West J Med 1993, 158:25–29.
13. Brin MF: Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Nerve Muscle 1997, 6(suppl):S146-S168.
14. Bhatia KP, Munchau A, Thompson PD, et al.: Generalized muscular weakness after botulinum toxin injections for dystonia: a report of three cases. J Neurol Neurosurg Psychiatry 1999, 67:90–93.
15. Cherington M: Clinical spectrum of botulism. Muscle Nerve 1998, 21:701–710.
16. Maselli RA: Pathogenesis of human botulism. Ann NY Acad Sci 1998, 841:122–139.
17. Thacket CO, Shandera WX, Mann JM, et al.: Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 1984, 76:794–798.
18. Black RE, Gunn RA: Hypersensitivity reactions associated with botulinal antitoxin. Am J Med 1980, 69:567–570.
19. Santos JI, Swensen P, Glasgow LA: Potentiation of Clostridium botulinum toxin by aminoglycoside antibiotics: clinical and laboratory observations. Pediatrics 1981, 68:50–54.
20. Mann JM, Martin S, Hoffman R, Marrazzo S: Patient recovery from type A botulism: morbidity assessment following a large outbreak. Am J Pub Health 1981, 71:266–269.